BioGend Therapeutics Market Cap

BioGend Therapeutics has a market cap or net worth of 3.58 billion as of July 22, 2025. Its market cap has decreased by -26.12% in one year.

Market Cap

3.58B

Enterprise Value

3.03B

Revenue

179.57M

Ranking

n/a

PE Ratio

n/a

Stock Price

28.85

Market Cap Chart

Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 3.58B, an increase of 32.08%. That is a compound annual growth rate of 4.67%.

Market Cap History

Date	Market Cap	% Change
Jul 22, 2025	3.58B	-14.26%
Dec 31, 2024	4.18B	-11.18%
Dec 29, 2023	4.71B	109.50%
Dec 30, 2022	2.25B	-18.50%
Dec 30, 2021	2.76B	-22.86%
Dec 31, 2020	3.57B	46.27%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	188.45B
PharmaEssentia	181.63B
Bora Pharmaceuticals Co., LTD.	86.16B
Lotus Pharmaceutical	58.37B
Oneness Biotech	31.42B
Polaris Group	29.16B
Center Laboratories	26.92B
TaiMed Biologics	23.62B

Market Cap Rankings